Table 2.
Differences between and in persons with Parkinson's disease before and after seven weeks of participation in the National Parkinson School (intervention group) and after seven weeks of ordinal care (control group)a.
| Intervention group (n = 48) | Control group (n = 44) | P-valueb | ||
|---|---|---|---|---|
| Health status (PDQ-8)d | Baseline | 28.1 (17.2–39.1) | 25 (12.5–37.5) | 0.301 |
| Follow-up | 23.4 (14.8–37.5) | 23.4 (13.3–37.5) | 0.713 | |
| P-valuec | 0.028 | 0.644 | ||
|
| ||||
| Health valuation (EQ5D)e | Baseline | 0.87 (0.71–0.93) | 0.86 (0.79–0.93) | 0.473 |
| Follow-up | 0.88 (0.78–0.93) | 0.86 (0.79–0.91) | 0.279 | |
| P-valuec | 0.023 | 0.866 | ||
|
| ||||
| Health education impact (heiQ)f | ||||
| Health-directed activities | Baseline | 3.25 (2.75–3.75) | 3.25 (2.75–3.75) | 0.865 |
| Follow-up | 3.25 (2.75–3.75 | 3 (2.75–3.50) | 0.344 | |
| P-valuec | 0.323 | 0.437 | ||
|
| ||||
| Positive and active engagement in life | Baseline | 2.8 (2.6–3.2) | 3 (2.6–3.4) | 0.088 |
| Follow-up | 3 (2.8–3.2) | 3 (2.6–3.4) | 0.945 | |
| P-valuec | 0.058 | 0.150 | ||
|
| ||||
| Emotional distress | Baseline | 2 (1.5–2.67) | 2.17 (1.83–2.67) | 0.529 |
| Follow-up | 2 (1.5–2.46) | 1.83 (1.33–2.5) | 0.536 | |
| P-valuec | 0.436 | 0.020 | ||
|
| ||||
| Self-monitoring and insight | Baseline | 2.83 (2.58–3.17) | 3 (2.5–3.17) | 0.445 |
| Follow-up | 3 (2.71–3.17) | 3 (2.67–3.17) | 0.652 | |
| P-valuec | 0.572 | 0.285 | ||
|
| ||||
| Constructive attitudes and approaches | Baseline | 3 (2.6–3.2) | 3 (2.8–3.6) | 0.075 |
| Follow-up | 3 (2.8–3.4) | 3.2 (2.8–3.6) | 0.971 | |
| P-valuec | 0.003 | 0.845 | ||
|
| ||||
| Skills and techniques acquisition | Baseline | 2.5 (2–2.75) | 2.88 (2.5–3.19) | 0.002 |
| Follow-up | 3 (2.5–3) | 2.75 (2.44–3) | 0.463 | |
| P-valuec | <0.001 | 0.464 | ||
|
| ||||
| Social integration and support | Baseline | 3 (2.4–3.6) | 3 (2.8–3.4) | 0.561 |
| Follow-up | 3 (2.8–3.6) | 3 (2.6–3.4) | 0.389 | |
| P-valuec | 0.110 | 0.324 | ||
|
| ||||
| Health service navigation | Baseline | 2.9 (2.4–3.2) | 3 (2.8–3.2) | 0.112 |
| Follow-up | 3 (2.6–3.6) | 3 (2.8–3.4) | 0.903 | |
| P-valuec | 0.286 | 0.368 | ||
|
| ||||
| Life satisfaction (LiSat-11)g | ||||
| Life as a whole | Baseline | 4 (4–5) | 5 (4–5) | 0.031 |
| Follow-up | 4.5 (4–5) | 4.5 (4–5) | 0.868 | |
| P-valuec | 0.117 | 0.011 | ||
|
| ||||
| Vocation | Baseline | 4 (3–5) | 4 (4–5) | 0.078 |
| Follow-up | 4 (4–5) | 4.5 (4–5) | 0.170 | |
| P-valuec | 0.159 | 0.157 | ||
|
| ||||
| Economy | Baseline | 5 (4–5) | 5 (5–5) | 0.077 |
| Follow-up | 4 (4–5) | 5 (4–5) | 0.042 | |
| P-valuec | 0.221 | 0.489 | ||
|
| ||||
| Leisure | Baseline | 4 (4–5) | 5 (4–5) | 0.105 |
| Follow-up | 4 (4–5) | 5 (4–5) | 0.889 | |
| P-valuec | 1.000 | 0.028 | ||
|
| ||||
| Contacts | Baseline | 5 (4–5) | 5 (4–5) | 0.472 |
| Follow-up | 5 (4–5) | 4 (4–5) | 0.481 | |
| P-valuec | 0.815 | 0.013 | ||
|
| ||||
| Sexual life | Baseline | 3 (2–4) | 3 (2–4) | 0.314 |
| Follow-up | 3 (2–4) | 3 (2–5) | 0.364 | |
| P-valuec | 1.000 | 0.414 | ||
|
| ||||
| ADL | Baseline | 5 (4–5) | 5 (4–6) | 0.289 |
| Follow-up | 5 (4–5) | 5 (4–6) | 0.401 | |
| P-valuec | 0.168 | 0.186 | ||
|
| ||||
| Family life | Baseline | 5 (4–6) | 5 (4–6) | 0.203 |
| Follow-up | 5 (4–6) | 5 (5–6) | 0.385 | |
| P-valuec | 0.729 | 0.712 | ||
| Partner relationship | Baseline | 5 (4–6) | 6 (4.5–6) | 0.266 |
| Follow-up | 5 (4.5–6) | 5 (5–6) | 0.841 | |
| P-valuec | 0.696 | 0.244 | ||
|
| ||||
| Somatic health | Baseline | 4 (3–4) | 4 (4–5) | 0.068 |
| Follow-up | 4 (3–4) | 4 (3–5) | 0.930 | |
| P-valuec | 0.263 | 0.054 | ||
|
| ||||
| Psychological health | Baseline | 4 (4–5) | 5 (4–5) | 0.367 |
| Follow-up | 4 (4–5) | 5 (4–5) | 0.088 | |
| P-valuec | 0.442 | 0.536 | ||
|
| ||||
| Fatigue (PFS-16)h | Baseline | 28 (19–38.8) | 32 (22–38) | 0.814 |
| Follow-up | 32 (20–38) | 27 (16–40) | 0.946 | |
| P-valuec | 0.164 | 0.832 | ||
aData are median (q1-q3). bMann–Whitney U test for comparisons between intervention and control groups. cWilcoxon's signed rank test for comparisons between baseline and follow-up within intervention and control groups. dPossible scores, 0–100 (100 = worse health status). ePossible scores, 0–1 (1 = better valued health state). fPossible stages, 1–4 (4 = better; except for emotional well-being, where 1 = better). gPossible scores, 1–6 (6 = higher life satisfaction). hPossible scores, 0–64 (64 = more fatigue). PDQ-8: the eight-item Parkinson's Disease Questionnaire; EQ5D: the five-dimensional EuroQol Questionnaire; heiQ: Health Education Impact Questionnaire; LiSat-11: the 11-item Life Satisfaction Checklist; PFS-16: the 16-item Parkinson Fatigue Scale.